AIDS2026: Is HIV remission the new cure?
By Heather Ellis This article was originally published in Positive Living. Set against Rio’s flamboyant backdrop of strong activism, AIDS2026 […]
Community
HIV cure updates from IAS Kigali
The latest in HIV treatment and PrEP from IAS 2025 by Heather Ellis Heather Ellis is a journalist, the communications
Time to HIV viral rebound and post-treatment controller in HIV cure studies with treatment interruptions
By Dr Jesper D Gunst, Dr Jesal Gohil, Dr Ole S Sogaard, Dr Sarah Fidler Researchers from Denmark and The
Inclusion, respect, equity: A photo essay of people participating in HIV cure research at The Alfred in Victoria.
This beautiful photographic essay was compiled by The Alfred in Melbourne, and all credit for this article goes to their
Cure update from IAS 2023
Dr Jillian Lau of the Doherty Institute and Alfred Health in Melbourne attended the recent IAS (International AIDS Society) HIV
Why we need more women in HIV cure trials
As the search for the elusive cure for HIV continues, researchers must take a lesson from the humble car safety
World AIDS Day COVID and cure chat
The COVID pandemic has touched everyone, including people living with HIV. Co-founder of The Institute of Many, Nic Dorward, spoke
All in the mix: bench, bedside, community
A terrific session is planned for this year’s joint HIV/AIDS and Sexual Health Conference on the Sunshine Coast. On Tuesday
Is a cure for HIV on the horizon?
A breakdown of the Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021 The landscape of
A roadmap for cure at AIDS 2022
The 24th International AIDS Conference takes place in Montréal, Canada and virtually from July 29th- August 2nd 2022. We have
Busting stigma, talking cure: podcast
The search for an HIV cure is the topic of a recent podcast. Created by Sydney-based producer Josh Green, the
Maintaining momentum: HIV cure research in the COVID era
The COVID-19 pandemic has devastated lives, healthcare systems and economies around the world. Research has not escaped unscathed. Clinical trials